Quick Summary

Atractylodes macrocephala is a traditional Chinese medicinal herb commonly used in combination with other herbal formulas. It has been studied for gastrointestinal disorders, advanced gastric cancer, irritable bowel syndrome (IBS), and various metabolic and immune-related conditions. Clinical evidence suggests it may help improve gastrointestinal symptoms, enhance immune function, and act as an adjunct to chemotherapy in advanced cancers. Its polysaccharides show promising preclinical intestinal protective effects. However, the quality of clinical evidence ranges from low to moderate, and further rigorous trials are needed.

What is it?

Atractylodes macrocephala, known simply as atractylodes, is a perennial herb used in traditional Chinese medicine. The rhizome of this plant is the part most commonly utilized. It is typically combined with other herbs in formulas to support digestive health, metabolism, and immune function.

Traditional Uses

  • Treatment of gastrointestinal conditions, including poor digestion and diarrhea
  • Supportive therapy for advanced gastric cancer
  • Management of irritable bowel syndrome, particularly diarrhea-predominant IBS
  • Part of formulations targeting metabolic dysfunction and immune enhancement
  • Support during chemotherapy in cancer patients

Active Compounds

The primary bioactive constituents include polysaccharides, which have shown immunomodulatory, intestinal barrier protective, and microbiota-modulating activities. Other components may contribute to its therapeutic effects in traditional use, but polysaccharides are the most studied in preclinical research.

Potential Benefits with Evidence Levels

  • Advanced Gastric Cancer (Adjunct to Chemotherapy) – Moderate evidence from systematic reviews and meta-analyses of randomized controlled trials (RCTs) suggests that Atractylodes-containing formulas combined with chemotherapy may improve response rates, disease control, quality of life, lymphocyte counts, and reduce chemotherapy-related adverse events compared to chemotherapy alone.
  • Irritable Bowel Syndrome (Especially Diarrhea-Predominant) – Low to moderate evidence from systematic reviews, meta-analyses, and trial sequential analysis indicates formulas with Atractylodes and Paeonia lactiflora may provide greater symptom relief and reduce IBS severity versus placebo or Western medications.
  • Non-Alcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) – Low-level evidence from reviews of traditional Chinese medicine formulas including Atractylodes suggests possible improvements in metabolic and liver biochemical measures, but these findings are limited by study quality and methodology.
  • Immune Function in Non-Small Cell Lung Cancer (NSCLC) – Moderate evidence from meta-analyses of multiple RCTs, network pharmacology, and immune infiltration studies identifies Atractylodes as a core herb in formulas that may enhance immune parameters (CD3+, CD4+ T cells) and quality of life when used adjunctively with chemotherapy.
  • Intestinal Disorders (IBS, Inflammatory Bowel Disease, Mucosal Injury) – Preclinical in vitro and animal studies show that polysaccharides from Atractylodes macrocephala exhibit microbiota-modulatory, immunomodulatory, epithelial-protective, and neuro-regulatory effects that support intestinal barrier integrity and reduce inflammation.

Side Effects

Adverse reactions associated with Atractylodes macrocephala are generally mild or absent. Some trials noted a reduction in chemotherapy-related adverse effects when Atractylodes-containing formulas were used adjunctively. However, comprehensive safety profiling is lacking, and safety data are incompletely reported in many studies.

Drug Interactions

There is limited direct evidence regarding specific drug interactions with Atractylodes macrocephala. Potential interactions may occur when combined with chemotherapy agents or other pharmaceuticals. Caution and monitoring are advised during co-administration, and further research is needed to clarify interaction risks.

Who Should Avoid It

Although no specific contraindications are well-documented, individuals with known hypersensitivity or allergies to Atractylodes products should avoid use. Due to insufficient safety data, pregnant or breastfeeding women should use caution and consult a healthcare provider before using this herb.

Evidence Limitations

Most clinical studies on Atractylodes macrocephala have limitations including small sample sizes, risk of bias, methodological heterogeneity, and short durations. Many studies originate from China and may lack rigorous blinding and placebo control. While preclinical data are promising, significant translational gaps exist. Larger, well-designed randomized controlled trials are necessary to confirm efficacy and safety.

References

Last Reviewed

April 2024

Disclaimer: This page is for informational purposes only and is not intended to provide medical advice. The information provided is based on current research and traditional uses of Atractylodes macrocephala but should not be used as a substitute for professional medical consultation, diagnosis, or treatment. Always consult a qualified healthcare provider before starting any new herbal supplement, especially if you are pregnant, breastfeeding, have existing medical conditions, or are taking medications.